Fadel Nammour, MD
Gastroenterology · Fargo, NDNPI 1922039684
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Covidien LP at 40.1% of the total. Reporting peaked in 2019 at $1,697 and has fallen 92.0% since, to $136 in 2024.
Across 50 payments — averaging $61.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$1K
- Medtronic$887
- Gilead$280
- Johnson & Johnson$236
- Apollo Endosurgery US Inc$88
- Takeda Pharmaceuticals U.S.A., Inc.$72
- plus $286 from 9 others
What the payments were for
- Travel & lodging$1,74857%
- Food & beverage$1,24340%
- Education$943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 4 | $1,236 |
| Medtronic | 3 | $887 |
| Gilead | 11 | $280 |
| Johnson & Johnson | 9 | $236 |
| Apollo Endosurgery US Inc | 2 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Bristol Myers Squibb | 4 | $65 |
| AbbVie(2 entities) | 3 | $56 |
| Romark Laboratories, LC | 1 | $36 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Organon | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,086 in reported general payments places this provider in the 80th percentile of 26 gastroenterology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 222 | $3,772 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 144 | $2,630 |
| Colesevelam Hcl | 12 | $809 |
| Omeprazole | 57 | $517 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 23 | $508 |
| Pantoprazole Sodium | 28 | $349 |
| Duloxetine Hcl | 17 | $168 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Fargo
- Arezoo TaheriFargo$28K
- Israr SheikhFargo$5K
- Surianarayanan KarthikeyanFargo$3K
- Kimberly KolkhorstFargo$947
- Ross MeidingerFargo$887
- Emuejevoke OkohFargo$772
- Navin PaulFargo$743
- Settihalli RajenderFargo$397
- Steven PletcherFargo$323
- Syed ZaidiBismarck$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.